BlackRock’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-253
| Closed | -$5.7K | – | 5531 |
|
|
2023
Q2 | $5.7K | Sell |
253
-80,452
| -100% | -$1.81M | ﹤0.01% | 5211 |
|
|
2023
Q1 | $976K | Sell |
80,705
-1,007
| -1% | -$12.2K | ﹤0.01% | 4262 |
|
|
2022
Q4 | $372K | Buy |
81,712
+83
| +0.1% | +$378 | ﹤0.01% | 4606 |
|
|
2022
Q3 | $535K | Sell |
81,629
-378
| -0.5% | -$2.48K | ﹤0.01% | 4620 |
|
|
2022
Q2 | $885K | Sell |
82,007
-49,821
| -38% | -$538K | ﹤0.01% | 4497 |
|
|
2022
Q1 | $2.52M | Sell |
131,828
-1,753
| -1% | -$33.5K | ﹤0.01% | 4210 |
|
|
2021
Q4 | $4.79M | Sell |
133,581
-338
| -0.3% | -$12.1K | ﹤0.01% | 3945 |
|
|
2021
Q3 | $9.84M | Buy |
133,919
+25,897
| +24% | +$1.9M | ﹤0.01% | 3622 |
|
|
2021
Q2 | $15.1M | Buy |
108,022
+9,188
| +9% | +$1.28M | ﹤0.01% | 3403 |
|
|
2021
Q1 | $28.7M | Buy |
98,834
+13,304
| +16% | +$3.87M | ﹤0.01% | 2929 |
|
|
2020
Q4 | $53.4M | Buy |
+85,530
| New | +$53.4M | ﹤0.01% | 2383 |
|